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(n=100) and healthcare professionals (n=96) tested seven synthetic protein samples and completed 23 a questionnaire, a feasibility study where pregnant women who were self-monitoring their blood 24 pressure were asked to self-test for proteinuria (n=30), and an online questionnaire about women's 25 experiences of self-testing (n=200). 26
Main outcome measures: Sensitivity and specificity of testing and questionnaire results. 27
Results: There were no significant differences in the accuracy of synthetic sample testing by 28 pregnant women (sensitivity 0.81 (95% confidence intervals (CI) 0.78-0.85), specificity 0.93 (95% CI 29 0.91-0.95) and healthcare professionals: (sensitivity 0.83 (95% CI 0.79-0.86), specificity 0.92 (95% CI 30 0.90-0.94)). Automated readers had significantly better sensitivity (0.94 (0.91-0.97) (p≤ 0.001 in each 31 case), but worse specificity 0.78 (0.69-0.85). Similar results were gained using self-tested urine 32 samples compared to staff-testing using a reference standard of laboratory urine protein-creatinine 33 ratio (uPCR) . Women who completed the online survey with experience of self-testing (n=39, 20%) 34 generally found it easy, and with support from healthcare professionals felt it improved involvement 35 in their care and reduced anxiety. 36
Introduction

45
Apart from blood pressure measurement, urinalysis for protein is the most commonly performed 46 antenatal screening test and is central to pre-eclampsia diagnosis.
(1) The development of 47
Methods
70
This was a mixed methods study combining test accuracy studies and questionnaires. There were 71 four parts comprising: 1) test accuracy study for 'proteinuria' (using synthetic samples to provide a 72 range of protein levels) comparing assessment by pregnant women, HCPs and an automated reader 73 to a laboratory reference standard; 2) self-testing of urine by pregnant women compared to testing 74 by HCPs and a laboratory reference standard; 3) a questionnaire to participating women and HCPs 75 and 4) an online questionnaire aiming to understand women's experience of self-testing and 76 opinions on its future use. 77
78
Test accuracy of urinary protein testing 79
Up to 50 pregnant women of any gestation and 50 HCPs from antenatal maternity services were 80 selected on a convenience basis from hospital sites in Oxfordshire (John Radcliffe and Horton 81 Hospitals, Ox) and London (St Thomas' Hospital, STH) between November 2015 and April 2016. 82 Following written informed consent, participants were provided with simple instructions for protein 83 testing, synthetic protein samples and standard dipstick reagent strips (a visually read enzymatic 84 test) (ALBUSTIX reagent strips, SIEMENS, Surrey UK). Protein solutions were prepared using bovine 85 serum albumin (Sigma-Aldrich, Dorset, UK) in 150 mmol/L sodium chloride (Fresenius Kabi Ltd, 86 Cheshire, UK). Sodium azide was added at a concentration of 100mg/L as a bacteriostat. Stock 87 solutions were produced at protein concentrations equivalent to seven different dipstick readings 88 between 'negative' and '3+' (≥500 mg/dL). The level of protein in the samples was confirmed by 89 repeated testing by urinary protein-creatinine ratio, (uPCR) (Supplementary Table 1 ). Samples were 90 tested by participating women and HCPs using visual determination as well as using an automated 91 reader (Clinitek Status+ Analyzer, SIEMENS, Surrey, UK) by the research team. Researchers and 92 participants were masked to the level of protein in each sample until recruitment and testing was 93 complete. Samples were re-tested following the study to confirm that storage and testing had not 94 resulted in contamination. participant to obtain sensitivity and specificity for each participant. In the case of missing data for an 127 individual, the sensitivity and specificity were calculated using the available samples. In order to 128 compare sensitivity and specificity per group, mean sensitivity and specificity were calculated, using 129 a threshold for a positive result of 1+ proteinuria (as errors across this threshold were considered 130 clinically important).(3) False positive and false negative rates were calculated and a logistic 131 regression model was used to compare the difference between the three groups (pregnant woman, 132 HCP, automated reader). All data were included. 133
134
Questionnaire analysis 135
Free text responses in the questionnaire and online survey were analysed using a thematic 136 approach. The qualitative data was read multiple times by researchers (KT, LB and PM) and analysed 137 using the 'one sheet of paper' (OSOP) method.(15) Themes were examined across the whole dataset 138 and in the context of individual responses.
Results
140
Test accuracy study 141
A total of 100 pregnant women and 96 HCPs performed dipstick urine testing on the seven synthetic 142 protein samples (Supplementary Figure 2) 2) (i.e. those around 1+ threshold (Table 1) between pregnant women (10% false negatives and 2% 151 false positives) and HCPs (10% false negatives and 4% false positives) when compared to laboratory 152 reference standards whereas the automated reader had fewer false negatives (4%) but more false 153 positives (10%). 154
155
There was no statistically significant differences between pregnant women and HCPs in sensitivity, 156 specificity (p=0.45 for both), positive predictive value or negative predictive value (p=0.58 for both); 157 however the automated reader had higher sensitivity, lower specificity, a lower positive predictive 158 value and higher negative predictive value (p= or < 0.001 in each case, Table 2 ) compared to 159 pregnant women and HCPs. 160
161
Self and healthcare professional proteinuria testing compared to a PCR reference standard 162
All 30 women who were approached agreed to self-test urine in conjunction with blood pressure 163 self-monitoring. Four women (13%) withdrew from the study (one due to pregnancy loss) before the 164 urine testing phase. The baseline characteristics of the participants are shown in Supplementary 
Questionnaire results 173
Of those who undertook the accuracy study, 99 (99%) pregnant women and 94 (98%) HCPs also 174 completed a questionnaire. Of women completing the questionnaire, 95 (96%) agreed that they 175 would be willing to check their urine at home and 89 (90%) thought it would make them feel more 176 involved in their care. All were potentially happy to share any urine testing results with their 177 midwife, family physician or obstetrician. There was very little discrepancy in responses between 178 women in Oxfordshire (Ox) and London (STH). (Figure 2 ) 179 180 Most HCPs respondents indicated that they would value self-testing by some women during their 181 pregnancy (n=83, 88%), and thought that proteinuria self-testing alongside blood pressure self-182 monitoring would add to usual care (n=73, 78%). However, the majority also stated that they would 183 always repeat urinalysis if a woman had already tested her urine (n=66, 69%). (Figure 2E ) 184 185 Free text responses were provided by 57 (58%) pregnant women and 67 (71%) HCPs who completed 186 the questionnaire, with similar proportions across sites (Quotes in Figure 3 ). Themes emerging from 187 analysis of these responses included reassurance from testing (women), the potential for earlier 188 detection (HCPs), potential for saving time (both) and concerns about women testing (both). Table 4 ) and most of these had found the dipsticks easy to 209 read (87%, n=34). Women reported positive experiences of self-testing, with all agreeing that it 210 helped them feel involved in their care, and only 10% (n=4) reporting increased anxiety levels due to 211 proteinuria self-testing. 212
213
Of 17 respondents who had previously tested, most indicated that prior experiences of pre-214 eclampsia motivated them to test their own urine and key themes were of reassurance, saving time 215 from negative results in this setting (PT1). One woman found self-testing useful because she 217 perceived that it was less influenced by her immediate anxiety level compared to blood pressure 218 readings (PT2). Three women said that they were reassured by self-monitoring between scheduled 219 antenatal appointments, and that this prevented unnecessary trips to the hospital. One woman 220 commented on the value of a positive proteinuria result (PT3) (Figure 4) . 221
222
Of those women who had not experienced self-testing for proteinuria (81%, n=161), the majority 223 (99%, n=159) said they would be willing to check their own urine for protein after training 224 (Supplementary Table 5 ). The majority (97%, n=155) said that self-testing would help them feel more 225 involved in their pregnancy care. Conversely, 26 women (17%) agreed or strongly agreed with the 226 statement that self-testing would increase their anxiety during pregnancy (Supplementary Table 5) . 227
228 Women who had not tested their own urine had similar themes of reassurance and empowerment 229 to those that had self-tested, with additional issues raised of training and HCPs' attitudes. 230
Reassurance appeared particularly important in those who had previous experience of pre-231 eclampsia or hypertension (NT1) Urine testing could reduce rather than increase anxiety (NT2): 232 Adequate training, explanation and clear instructions could also reduce any anxiety they felt (NT3). 233
The women emphasised that it was important that HCPs were receptive to the results (NT4) (Figure  234 4). 235
Discussion
237
Main Findings 238
This study has shown that pregnant women and HCPs were able to test for proteinuria over a range 239 of protein concentrations with similar levels of accuracy. As with previous research, testing by 240 women and HCPs was less sensitive but more specific than automated testing using a reference 241 standard of laboratory uPCR. Overall self-testing was acceptable to both pregnant women and HCPs 242 both theoretically and alongside blood pressure self-monitoring. Self-testing was perceived as 243 providing reassurance and convenience for women, particularly those with previous experience of 244 hypertensive disease in pregnancy, though there were some concerns as to whether HCPs would 245 always trust the results provided by pregnant women. Women felt that support from their HCPs 246 would be important, perhaps reflecting the reticence of professionals to act on women's own 247
results. 248 249
Strengths and Limitations 250
This mixed methods study has included a relatively large number of women and HCPs who tested 251 samples over a range of protein concentrations both on synthetic and real urine, providing 252 comprehensive data on test accuracy. Use of synthetic urine samples ensured that sufficient 253
numbers of positive samples were tested, and whilst the numbers testing their own urine were 254 relatively small (n=26) and for a limited period they provided similar results and were representative 255 of women who might be asked to undertake such testing. This suggests that it is unlikely that the 256 accuracy of testing would be altered in a clinical vs home setting, though the experience may be. 257
Previous pilot work of self-testing of blood pressure in pregnancy completed by this group has 258 indicated that women found blood pressure monitoring acceptable and reassuring. Women who 259 completed proteinuria testing in the home environment were positive about the experience but 260 further work on the experience of regular self-testing through pregnancy is required. 261
Questionnaire and online survey data gathered views from a large number of participants including 263 currently pregnant women, those with and without experience of self-testing, women with both 264 hypertensive and normotensive pregnancies and a variety of HCPs providing a range of experiences 265 and opinions. The majority of online survey participants had experienced hypertensive disorders of 266 pregnancy, and therefore those most likely to be considered for additional home testing. The survey 267 provided both quantitative and qualitative data providing an in-depth understanding of views and 268 experiences. The similarity between the questionnaire results of pregnant women and the online 269 survey findings suggest broad acceptability and appeal of self-testing. 270 271 Some selection bias from the online survey is possible as respondents were limited to internet users; 272 however, most of the target population will be web connected,(16). By engaging with the charity 273 APEC and responding to the online survey, the participants were likely to be individuals with 274 previous experience, who had sought extra information and support, and may therefore be more 275 motivated to adopt health behaviours such as proteinuria self-testing. 276
277
Comparison with previous work 278
There are surprisingly few data on proteinuria self-testing in the pregnant population. A 2002 279
Australian study showed that women interpreting results in clinic had a tendency to overestimate 280 proteinuria compared to the midwife performing the same test; the authors suggested that self-281 testing of urine during pregnancy could be easily implemented at antenatal visits. (10) More 282 recently, large screening studies undertaken within the general non-pregnant population for early 283 detection of renal disease found that self-testing improves the chances for early diagnosis and 284 therapy, though participants tended to report false positives for proteinuria. (17, 18) 285 286 There is heterogeneity in the reported sensitivity and specificity of testing with reagent strips within 287 the literature across patient and staff groups, and limited data from studies in pregnancy. Bell et alused five albumin samples to look at the accuracy of testing and reported a high false positive rate 289 for the two non-proteinuric samples (nursing auxiliaries; 40% and 55% and midwives; 5% and 30%). 290
For the three positive samples both groups recorded false negative rates of between 10-45%. (19) 291 While automated readers had higher sensitivity, they also produced a lower specificity, i.e. yielding 292 more false positive results that may lead to unnecessary anxiety and additional appointments and 293 testing for some women. (20, 21) These studies compare to false positive rates of only 2-4% in our 294 study; the majority of false negative results related to differences between negative and trace 295 amounts of proteinuria, and would therefore not have changed clinical action. The results of this study are an important first step in considering the potential for self-monitoring 313 for proteinuria in pregnancy. This inexpensive, simple and rapid test could improve detection of preeclampsia, a potentially serious condition, and be used to reduce additional appointments required 315 by some pregnant women (thereby alleviating burden on women and healthcare resources). Self-316 testing was acceptable and well received in a population of women who were at increased risk of 317 pre-eclampsia. Participants were willing and able to test for proteinuria alongside blood pressure 318 self-monitoring during pregnancy and self-testing appears to be as accurate as testing by HCPs. A full 319 evaluation of the impact on detection rates of proteinuria and pre-eclampsia, cost effectiveness, 320 pregnancy outcomes and women's experiences of regularly completing self-testing is needed before 321 considering adopting self-monitoring more widely during pregnancy. 322
323
Intended population 324
This pilot work confirms that women at higher risk of pre-eclampsia are willing and able to complete 325 this testing. The most suitable population for regular proteinuria self-testing may be pregnant 326 women who have developed hypertension or those at high risk within the second half of pregnancy 327 when pre-eclampsia is most likely to develop. 328
329
Barriers 330
While testing for urinary protein and monitoring of blood pressure are known to be of value during 331 pregnancy, self-testing is unlikely to be suitable for all women. In addition, HCPs will need evidence 332 to be convinced about the benefits of self-testing and require clear pathways to follow alongside 333 current care. 334
335
Conclusion 336
This research suggests that self-testing of proteinuria is feasible, acceptable and potentially 337 advantageous for both pregnant women and HCPs. If shown to be sufficiently accurate when tested 338 at scale and is cost effective, proteinuria self-testing has the potential to be a valuable method ofscreening for pre-eclampsia in pregnancy, and may result in earlier diagnosis of this condition than 340 current practice. Results are shown as a proportion of women answering to allow comparisons between groups.
*each sample tested at least twice in each machine. 
Figure2
Quotes from free text responses "Being high risk myself I feel it would give peace of mind and less stress of running to the GP constantly to be able to test your urine at home" (STH 34).
"I think that self-monitoring is very useful to save health professionals time and the women's time in going to appointments. I believe it is also empowering for the women." (Ox 53)
"The testing procedure is simple, although the results are sometimes hard to interpret if they are 'in between' colours" (STH 38).
"Some mums might not feel capable doing it if they are not trained and would want someone who has training to check it to be sure that they are getting the right answer" (STH 30).
"I'd worry about women forgetting to do it or saying they would and making up normal results to avoid being high risk." (STH 19) . Quotes from the free text section in the online survey PT1 "I found it hugely reassuring to be able to check this myself at home, it was empowering and took away the anxiety around appointments." PT2 "Also knowing how nervous I was about BP (therefore how it can fluctuate sometimes with stress levels) I also wanted something to measure that couldn't be influenced by anxiety or stress." PT3 "The dipsticks gave me the confidence to go back in [to the hospital], which was the right decision to make." NT1 "Having got severe PET and HELLP a few hours after birth with my firstborn I know that if I have another I would be really anxious about it occurring in pregnancy and would feel worried in between antenatal check-ups so it would reassure me."
NT2 "During pregnancy a lot felt out of my control and waiting between midwife appointments sometimes left me anxious. Self-testing would make me feel like I could do something myself to take away some anxiety".
NT3 "I also agree that it may cause more anxiety for some if the reading is not clear cut, as long as training and reference points are clear for mothers I do believe this would be beneficial overall." NT3 "GP surgeries need to be better briefed as well on this, otherwise patients could self-test and still the doctor ignores the signs." *each sample tested at least twice in each machine. 
Pregnant women
